Literature DB >> 9430772

Pharmacokinetics of enrofloxacin in newborn and one-week-old calves.

L Kaartinen1, S Pyörälä, M Moilanen, S Räisänen.   

Abstract

The pharmacokinetic behaviour of enrofloxacin was compared in four one-day-old and four one-week-old calves in order to find out if there were any age-related differences. Mean volume of distribution (Vd(ss)) and clearance (Cl) were significantly smaller in newborn calves: Vd(ss) was 1.8 and 2.3 L/kg, while clearance was 0.19 and 0.39 L/kg.h in newborn and one-week-old calves, respectively. Mean elimination half-life (t1/2 beta) did not differ significantly in newborn and in one-week-old calves: mean t1/2 beta was 6.6 h and 4.9 h, respectively. Enrofloxacin was metabolized to ciprofloxacin both by newborn and one-week-old calves, but the maximum concentration (Cmax) of ciprofloxacin was lower and the time when maximum concentration was reached (tmax) later in newborn calves. We conclude that the dosage of enrofloxacin should be adjusted according to age when administered to very young calves.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430772     DOI: 10.1046/j.1365-2885.1997.00100.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  10 in total

Review 1.  Pharmacokinetics and pharmacodynamics in the newborn.

Authors:  I Eberini
Journal:  Vet Res Commun       Date:  2008-09       Impact factor: 2.459

2.  Pharmacokinetic disposition of subcutaneously administered enrofloxacin in goats.

Authors:  S Ramesh; G S Rao; J K Malik
Journal:  Vet Res Commun       Date:  2002-10       Impact factor: 2.459

3.  Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats.

Authors:  M Elmas; B Tras; S Kaya; A L Bas; E Yazar; E Yarsan
Journal:  Can J Vet Res       Date:  2001-01       Impact factor: 1.310

4.  Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intramuscular administration of enrofloxacin in goats.

Authors:  G S Rao; S Ramesh; A H Ahmad; H C Tripathi; L D Sharma; J K Malik
Journal:  Vet Res Commun       Date:  2001-04       Impact factor: 2.459

5.  Influence of systemic fluoroquinolone administration on the presence of Pasteurella multocida in the upper respiratory tract of clinically healthy calves.

Authors:  Boudewijn Catry; Siska Croubels; Stefan Schwarz; Piet Deprez; Bianca Cox; Corinna Kehrenberg; Geert Opsomer; Annemie Decostere; Freddy Haesebrouck
Journal:  Acta Vet Scand       Date:  2008-09-22       Impact factor: 1.695

6.  Systemic and mammary gland disposition of enrofloxacin in healthy sheep following intramammary administration.

Authors:  Cristina López; Juan José García; Matilde Sierra; María José Diez; Claudia Pérez; Ana Maria Sahagún; Nélida Fernández
Journal:  BMC Vet Res       Date:  2015-04-09       Impact factor: 2.741

7.  Pharmacokinetic-pharmacodynamic integration of enrofloxacin and its metabolite ciprofloxacin in buffalo calves.

Authors:  Prashant S Daundkar; Bhaskar Vemu; Vinod K Dumka; Suresh K Sharma
Journal:  Vet Med Sci       Date:  2015-11-26

8.  Pharmacokinetics in plasma and alveolar regions of healthy calves subcutaneously administered a single dose of enrofloxacin.

Authors:  Tetsuro Kuramae; Konosuke Otomaru; Masaya Hirata; Shingo Ishikawa; Michiko Noguchi; Tomonobu Ikedo; Chie Horinouchi; Jun Hayashi; Keita Tsumagari; Seiji Hobo
Journal:  J Vet Med Sci       Date:  2020-07-19       Impact factor: 1.267

9.  Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes.

Authors:  Nitwarat Ruennarong; Kannika Wongpanit; Chainarong Sakulthaew; Mario Giorgi; Susumu Kumagai; Amnart Poapolathep; Saranya Poapolathep
Journal:  J Vet Med Sci       Date:  2015-11-20       Impact factor: 1.267

10.  Comparisons of plasma and fecal pharmacokinetics of danofloxacin and enrofloxacin in healthy and Mannheimia haemolytica infected calves.

Authors:  Ashenafi Feyisa Beyi; Jonathan P Mochel; Géraldine Magnin; Tyler Hawbecker; Clare Slagel; Grant Dewell; Renee Dewell; Orhan Sahin; Johann F Coetzee; Qijing Zhang; Paul J Plummer
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.